GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Propanc Biopharma Inc (OTCPK:PPCB) » Definitions » Cyclically Adjusted Book per Share

PPCB (Propanc Biopharma) Cyclically Adjusted Book per Share : $-1,327.91 (As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Propanc Biopharma Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Propanc Biopharma's adjusted book value per share for the three months ended in Dec. 2024 was $-277.267. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $-1,327.91 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2025-04-13), Propanc Biopharma's current stock price is $2.54. Propanc Biopharma's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was $-1,327.91. Propanc Biopharma's Cyclically Adjusted PB Ratio of today is .


Propanc Biopharma Cyclically Adjusted Book per Share Historical Data

The historical data trend for Propanc Biopharma's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Propanc Biopharma Cyclically Adjusted Book per Share Chart

Propanc Biopharma Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -1,991.98

Propanc Biopharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,564.00 -2,724.02 -1,991.98 -1,590.57 -1,327.91

Competitive Comparison of Propanc Biopharma's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Propanc Biopharma's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Propanc Biopharma's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Propanc Biopharma's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Propanc Biopharma's Cyclically Adjusted PB Ratio falls into.


;
;

Propanc Biopharma Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Propanc Biopharma's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book= Book Value per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-277.267/129.4637*129.4637
=-277.267

Current CPI (Dec. 2024) = 129.4637.

Propanc Biopharma Quarterly Data

Book Value per Share CPI Adj_Book
201503 0.000 99.187 0.000
201506 0.000 99.838 0.000
201509 0.000 100.302 0.000
201512 0.000 100.673 0.000
201603 0.000 100.488 0.000
201606 0.000 100.859 0.000
201609 0.000 101.602 0.000
201612 0.000 102.159 0.000
201703 0.000 102.624 0.000
201706 0.000 102.809 0.000
201709 0.000 103.460 0.000
201712 0.000 104.110 0.000
201803 0.000 104.574 0.000
201806 0.000 104.945 0.000
201809 0.000 105.410 0.000
201812 0.000 105.967 0.000
201903 0.000 105.967 0.000
201906 0.000 106.617 0.000
201909 0.000 107.174 0.000
201912 0.000 107.917 0.000
202003 0.000 108.289 0.000
202006 0.000 106.246 0.000
202009 0.000 107.917 0.000
202012 0.000 108.846 0.000
202103 0.000 109.496 0.000
202106 0.000 110.332 0.000
202109 0.000 111.168 0.000
202112 0.000 112.654 0.000
202203 0.000 115.069 0.000
202206 0.000 117.112 0.000
202209 0.000 119.248 0.000
202212 0.000 121.477 0.000
202303 0.000 123.148 0.000
202306 0.000 124.170 0.000
202309 0.000 125.656 0.000
202312 -3,564.000 126.399 -3,650.416
202403 -1,850.000 127.606 -1,876.930
202406 -472.375 128.906 -474.417
202409 -373.455 129.185 -374.261
202412 -277.267 129.464 -277.267

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Propanc Biopharma  (OTCPK:PPCB) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Propanc Biopharma Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Propanc Biopharma's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Propanc Biopharma Business Description

Industry
Traded in Other Exchanges
N/A
Address
302, 6 Butler Street, Cambwerwell, VIC, AUS, 3124
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Executives
Josef Zelinger director 59 SEYMOUR ROAD, ELSTERNWICK C3 3185
Carlo M Campiciano officer: CFO & Secretary C/O. PROPANC BIOPHARMA,INC., 302, 6 BUTLER STREET, CAMBERWELL C3 3124
Julian Norman Kenyon director BEECHWOOD, EMBLEY LANE, EAST WELLOW, ROMSEY HAMPSHIRE X0 SO516DN
James Andrew Nathanielsz director, officer: CEO, CFO, Secretary, Treasurer 1/76 SUMMERHILL ROAD, GLEN IRIS, VICTORIA C3 3146